MarkJRussoMD
Thoracic Surgery • New Brunswick, NJAdult Cardiac Surgery, Aortic Surgery, Cardiopulmonary Transplantation, Cardiovascular Surgery
Professor of Surgery Chief of cardiac surgery Director of Structural Heart Disease
Dr. Russo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Robert Wood Johnson Pl
New Brunswick, NJ 08901Phone+1 732-828-3000Fax+1 413-599-0470
Summary
- Dr. Russo is the Chief of Cardiac Surgery; the Director of Structural Heart Disease; and Associate Professor of Surgery at Rutgers-Robert Wood Johnson Medical School.
An internationally known expert in the treatment of heart valve disease, Dr. Russo specializes in complex and reoperative aortic and valvular surgery. To achieve the best possible patient outcomes, Dr. Russo uses leading-edge technologies, including minimally invasive, endovascular, and hybrid approaches; transcatheter valve replacement (including TAVR and Mitraclip); valve-sparing procedures; and advanced cardio-pulmonary perfusion techniques.
Education & Training
NYP Hosp-Columbia Univ Med Ctr2011
New York Presbyterian Hospital (Cornell Campus)Fellowship, Thoracic Surgery, 2008 - 2010- New York Presbyterian Hospital (Columbia Campus)Residency, Thoracic Surgery - Integrated, 2002 - 2008
- New York Presbyterian Hospital (Columbia Campus)Internship, Surgery, 2002 - 2003
Albert Einstein College of MedicineClass of 2002
Certifications & Licensure
FL State Medical License 2021 - 2025
NJ State Medical License 2012 - 2025
CT State Medical License 2021 - 2023
NY State Medical License 2004 - 2020
AZ State Medical License 2010 - 2014
IL State Medical License 2010 - 2014- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
- IL, NY, AZ
Clinical Trials
- Sodium Bicarbonate in Cardiac Surgery Study Start of enrollment: 2008 May 01
- Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure Start of enrollment: 2008 Aug 01
- Surgical Ablation Versus No Surgical Ablation for Patients With Atrial Fibrillation Undergoing Mitral Valve Surgery Start of enrollment: 2010 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 54 citationsPosttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices.Mark J. Russo, Kimberly N. Hong, Ryan R. Davies, Jonathan M. Chen, Robert Sorabella
The Journal of Thoracic and Cardiovascular Surgery. 2009-12-01 - 172 citationsOutcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk.Martin B. Leon, Michael J. Mack, Rebecca T. Hahn, Vinod H. Thourani, Raj Makkar
Journal of the American College of Cardiology. 2021-03-09 - 22 citationsQuantifying the incremental cost of complications associated with mitral valve surgery in the United States.Alexander Iribarne, John D. Burgener, Kimberly N. Hong, Jai Raman, Shahab A. Akhter
The Journal of Thoracic and Cardiovascular Surgery. 2012-04-01
Press Mentions
Clinical Trial Evaluates Minimally Invasive Treatment of Severe Heart Valve DisorderJuly 26th, 2021- Dr. Partho Sengupta Joins Cardiovascular Service Line Team at Robert Wood Johnson University Hospital and Rutgers Robert Wood Johnson Medical SchoolJune 3rd, 2021
RWJ University Hospital First in NJ to Use New Valve Replacement TechnologySeptember 5th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
